Compare GMED & DAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GMED | DAR |
|---|---|---|
| Founded | 2003 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 9.7B |
| IPO Year | 2012 | 2002 |
| Metric | GMED | DAR |
|---|---|---|
| Price | $86.58 | $65.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $100.42 | $65.82 |
| AVG Volume (30 Days) | 1.4M | ★ 2.1M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 422.67 | N/A |
| EPS | 2.00 | ★ 3.24 |
| Revenue | $2,938,931,000.00 | ★ $6,135,877,000.00 |
| Revenue This Year | $11.13 | $7.78 |
| Revenue Next Year | $6.28 | $3.37 |
| P/E Ratio | $42.84 | ★ $20.94 |
| Revenue Growth | ★ 16.65 | 7.36 |
| 52 Week Low | $54.17 | $29.15 |
| 52 Week High | $101.40 | $69.98 |
| Indicator | GMED | DAR |
|---|---|---|
| Relative Strength Index (RSI) | 59.66 | 57.63 |
| Support Level | $85.01 | $57.61 |
| Resistance Level | $87.22 | N/A |
| Average True Range (ATR) | 2.58 | 2.53 |
| MACD | 0.32 | 0.42 |
| Stochastic Oscillator | 76.78 | 65.41 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Darling Ingredients Inc develops and produces sustainable natural ingredients from edible and inedible bio-nutrients for the pharmaceutical, food, pet food, animal feed, industrial, fuel, bioenergy, and fertilizer industries. The Company collects and processes animal by-products and recycled oils into ingredients. It operates through three reportable segments: Feed Ingredients, which generates maximum revenue and includes the collection and processing of animal by-products, used cooking oil, bakery residuals, pet food ingredients, hides, and fertilizers; Food Ingredients, which includes collagen, natural casings, and food-grade fats; and Fuel Ingredients, which includes renewable fuels, biogas, and energy products. The Company derives the majority of its revenue from North America.